According to Edwards Lifesciences's latest financial reports the company's current revenue (TTM) is $6.00 B. In 2022 the company made a revenue of $5.38 B an increase over the years 2021 revenue that were of $5.23 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $6.00 B | 11.56% |
2022 | $5.38 B | 2.86% |
2021 | $5.23 B | 19.29% |
2020 | $4.38 B | 0.88% |
2019 | $4.34 B | 16.79% |
2018 | $3.72 B | 8.37% |
2017 | $3.43 B | 15.91% |
2016 | $2.96 B | 18.85% |
2015 | $2.49 B | 7.35% |
2014 | $2.32 B | 13.56% |
2013 | $2.04 B | 7.68% |
2012 | $1.89 B | 13.17% |
2011 | $1.67 B | 16.01% |
2010 | $1.44 B | 9.51% |
2009 | $1.32 B | 6.76% |
2008 | $1.23 B | 13.44% |
2007 | $1.09 B | 5.19% |
2006 | $1.03 B | 3.95% |
2005 | $0.99 B | 7.13% |
2004 | $0.93 B | 8.25% |
2003 | $0.86 B | 22.23% |
2002 | $0.70 B | 1.73% |
2001 | $0.69 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Medtronic MDT | $32.32 B | 438.24% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | $14.24 B | 137.14% | ๐บ๐ธ USA |
Merit Medical MMSI | $1.25 B | -79.06% | ๐บ๐ธ USA |
LeMaitre Vascular LMAT | $0.19 B | -96.78% | ๐บ๐ธ USA |
ICU Medical
ICUI | $2.25 B | -62.38% | ๐บ๐ธ USA |
CryoLife CRY | $0.29 B | -95.02% | ๐บ๐ธ USA |